nach oben

Erschienen in:

01.07.2010

Humoral and Cellular Immune Responses to Measles and Tetanus: The Importance of Elapsed Time Since Last Exposure and the Nature of the Antigen

verfasst von: Patricia O. Viana, Erika Ono, Maristela Miyamoto, Reinaldo Salomao, Beatriz T. Costa-Carvalho, Lily Y. Weckx, Maria Isabel de Moraes-Pinto

Erschienen in: Journal of Clinical Immunology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

This study aims to assess the cellular and humoral immune response pre- and post-vaccine rechallenge in healthy adults with previous exposure to measles (virus or vaccine) and different time intervals since last tetanus vaccine.

Methods

Humoral immunity was tested by ELISA, and cellular immunity was tested by intracellular interferon gamma detection after in vitro stimulation with antigens.

Results

While cellular immunity was comparable among vaccinated individuals and those who had measles, higher antibody levels were found in those who had the disease in the past. Both antibodies and CD4⁺ T cell tetanus immune responses depended on elapsed time since last immunization. Following a vaccine booster, an increase in cellular immunity and antibodies was observed to both tetanus and measles. Measles humoral response was much more intense among individuals previously exposed to a wild virus.

Conclusions

In an era when natural boosters are less frequent, an immune surveillance might be necessary to investigate waning immunity as occurs for tetanus.

Plotkin SA. Vaccines: past, present and future. Nat Med. 2005;11(4):S5–11.CrossRefPubMed

Kaufmann SHE. The contribution of immunology to the rational design of novel antibacterial vaccines. Nat Rev Microbiol. 2007;5(7):491–504.CrossRefPubMed

Maino VC, Maecker HT. Cytokine flow cytometry: a multiparametric approach for assessing cellular immune responses to viral antigens. Clin Immunol. 2004;110:222–31.CrossRefPubMed

World Health Organization (WHO): Measles imported cases in Santa Catarina, Brazil. EID Weekly Updates: emerging and reemerging infection diseases, Region of the Americas. http://www.paho.org/English/AD/DPC/CD/eid-eer-24-dec-2003.htm. Accessed 28 Sep 2009.

Borrow R, Balmer P, Roper MH. The immunological basis for immunization series. Module 3: tetanus. Geneva: World Health Organization; 2006. p. 1–52.

Gaines H, Biberfeld G. Measurement of lymphoproliferation at the single-cell level by flow cytometry. Methods Mol Biol. 2000;134:243–55.PubMed

Pala P, Hussell T, Openshaw PJM. Flow cytometric measurement of intracellular cytokines. J Immunol Methods. 2000;243:107–24.CrossRefPubMed

Kristiansen M, Aggerbeck H, Heron I. Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera. Acta Pathol Microbiol Scand. 1997;105:843–53.

de Moraes-Pinto MI, Almeida ACM, Kenj G, Filgueiras TE, Tobias W, Santos AMN, et al. Placental transfer and maternally acquired neonatal Igg immunity in HIV infection. J Infect Dis. 1996;173:1077–84.PubMed

10.

Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, et al. Measles antibody: reevaluation of protective titers. J Infect Dis. 1990;162:1036–42.PubMed

11.

Chaves SS, Gargiullo P, Zhang JX, Civen R, Guris D, Mascola L, et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med. 2007;356(11):1121–9.CrossRefPubMed

12.

Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15–18 years after neonatal immunization. J Infect Dis. 2008;197:1419–26.CrossRefPubMed

13.

Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S, Masopust D, et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity. 2008;28(5):710–22.CrossRefPubMed

14.

Costantini A, Mancini S, Giuliodoro S, Butini L, Regnery CM, Silvestri G, et al. Effects of cryopreservation on lymphocyte immunophenotype and function. J Immunol Methods. 2003;278:145–55.CrossRefPubMed

15.

Suni MA, Picker LJ, Maino VC. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry. J Immunol Methods. 1998;212:89–98.CrossRefPubMed

16.

Nanan R, Rauch A, Kämpgen E, Niewiesk S, Kreth HW. A novel sensitive approach for frequency analysis of measles virus-specific memory T-lymphocytes in healthy adults with a childhood history of natural measles. J Gen Virol. 2000;81:1313–9.PubMed

17.

Ovsynnikova IG, Dhiman N, Jacobson RM, Vierkant RA, Poland GA. Frequency of measles virus-specific CD4⁺ and CD8⁺ T cells in subjects seronegative or highly seropositive for measles vaccine. Clin Diagn Lab Immunol. 2003;10(3):411–6.

18.

Christenson B, Bottinger M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine. 1994;12(2):129–33.CrossRefPubMed

19.

Caglar K, Karakus R, Aybay C. Determination of tetanus antibodies by double-antigen enzyme-linked immunosorbent assay in individuals of various age groups. Eur J Clin Microbiol Infect Dis. 2005;24:523–8.CrossRefPubMed

20.

Lambert PH, Liu M, Siegrist CA. Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med. 2005;11(4):S54–62.CrossRefPubMed

21.

Mossong J, Nokes DJ, Edmunds WJ, Cox MJ, Ratnam S, Muller CP. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am J Epidemiol. 1999;150:1238–49.PubMed

22.

LeBaron CW, Beeler J, Bradley J, Sullivan BJ, Forghani B, Bi D, et al. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. Arch Pediatr Adolesc Med. 2007;161:294–301.CrossRefPubMed

23.

Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008;197(7):950–6.CrossRefPubMed

24.

Putz MM, Bouche FB, Swart RL, Muller CP. Experimental vaccines against measles in a world of changing epidemiology. Int J Parasitol. 2003;33:525–45.CrossRefPubMed

25.

Manz RA, Arce S, Cassese G, Hauser AE, Hiepe F, Radbruch A. Humoral immunity and long-lived plasma cells. Curr Opin Immunol. 2002;14(4):517–21.CrossRefPubMed

26.

Slifka MK, Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol. 1998;10(3):252–8.CrossRefPubMed

Titel: Humoral and Cellular Immune Responses to Measles and Tetanus: The Importance of Elapsed Time Since Last Exposure and the Nature of the Antigen
verfasst von: Patricia O. Viana
Erika Ono
Maristela Miyamoto
Reinaldo Salomao
Beatriz T. Costa-Carvalho
Lily Y. Weckx
Maria Isabel de Moraes-Pinto
Publikationsdatum: 01.07.2010
Verlag: Springer US
Erschienen in: Journal of Clinical Immunology / Ausgabe 4/2010
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-010-9420-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Humoral and Cellular Immune Responses to Measles and Tetanus: The Importance of Elapsed Time Since Last Exposure and the Nature of the Antigen